Fort Lauderdale Attorneys for Aduhelm Lawsuits
Controversial Alzheimer's Drug Linked to Brain Bleeds, Death
Aduhelm (aducanumab) is a new but already highly controversial Alzheimer's drug. The public concern over the drug has skyrocketed since the death of a 75-year-old woman and clinical trial participant. Sadly, her tragic death is only the tip of the iceberg.
As reported by The New York Times, 41% of patients who were given the highest dose of Aduhelm in its key clinical trials experienced brain bleeding or swelling. This is the same dose that would later be approved by the U.S. Food and Drug Administration (FDA) in June 2021.
Dedicated Trial Attorneys Fighting for Justice
If you or a loved one has been injured after taking Aduhelm, we urge you to contact our South Florida product liability attorneys. At Schlesinger Law Offices, P.A., we are highly skilled in bringing forth claims over defective and dangerous drugs. With more than 70 years of legal experience, we will fight tirelessly to hold Aduhelm’s manufacturer, Biogen, accountable for the harm it has caused you and your family.
Learn more about how we can help with your personal injury case during a free initial evaluation. Give our award winning attorneys a call at (954) 467-8800, or contact us online to schedule a time to speak with a member of our team.
-
$60 Million Product LiabilityThe firm obtained a $60,000,000.00 verdict against General Motors after the vehicle the McGee family was driving was engulfed in flames due to a fuel-fed fire, and Shane McGee was tragically burned to death. Gregg helped litigate the matter and prepare it for trial.
-
$37 Million Product LiabilityJury verdict for the family of our client, who died of lung cancer after a lifetime of smoking R.J. Reynolds and Philip Morris cigarettes.
-
$20 Million Product LiabilityAttorneys Scott Schlesinger and Jonathan Gdanski recently secured a $20 million jury verdict for Herbert Landi, the widower of a woman who died of lung cancer in 1999 caused by smoking cigarettes.
What Is Aduhelm?
Aduhelm is the first drug the FDA has approved in almost 20 years that aims to treat Alzheimer's disease, a progressive neurologic disease marked by issues with memory and other key mental functions.
According to Biogen, Aduhelm is a monoclonal antibody that may stop the progression of Alzheimer’s by clearing out protein formations called amyloid plaques. While it has been shown to target these amyloid plaques “very effectively,” as The Times quoted Dr. Aaron Kesselheim (a medical professor at Brigham and Women's Hospital in Boston), the clinical trials do not show whether this stops the progression of Alzheimer’s at all. Worse, the drug has been linked to brain bleeds and swelling in about 41% of study participants.
Administered as a monthly infusion, Aduhelm’s price tag sits at a whopping $56,000 a year.
About the Aduhelm Controversy
The FDA approved Aduhelm in June of 2021, going against the professional opinions of a council of senior FDA officials, numerous Alzheimer’s specialists, and an advisory committee of external experts, The Times reported.
There Are Two Main Issues at the Heart of the Aduhelm Controversy:
- There is insufficient evidence that the drug works to stop the progression of Alzheimer’s; and
- The drug has been proven to have very serious side effects, namely brain swelling and brain bleeds, which can lead to serious or fatal injury.
Aducanumab Side Effects
The FDA has warned patients and their families that Aduhelm may lead to amyloid-related imaging abnormalities (ARIA), a brain side effect that can be seen in an MRI.
Other Common Adverse Side Effects Include but Are Not Limited To:
- Brain swelling
- Brain bleeds
- Confusion
- Headaches
- Dizziness
- Nausea
- Fatigue
- Blurred vision
- Visual impairment
- Gait disturbance/trouble walking
It is also important to note that the trials failed to consider how the drug could impact patients who have medical issues common among older people, such as impaired liver/kidney function and cardiac problems. How individuals with these health conditions may react to the drug has yet to be determined.
Find Out if an Aduhelm Lawsuit in Florida Is Right for You
When manufacturers put defective drugs on the market, they can be held accountable for their negligence through a product liability lawsuit. This is because they have a legal and moral obligation to test their products to ensure they are safe for the public. At Schlesinger Law Offices, P.A. in South Florida, we are known for holding negligent companies like these accountable when they put profit over public safety—often, we do so through multimillion-dollar lawsuits.
Let our Fort Lauderdale product liability attorneys fight for you! In a free consultation, we can discuss your options and help you make an informed decision about your next steps. You could be entitled to compensation for your pain and suffering, medical bills, and loss of earnings, among other damages.
I can't thank the team of lawyers from Schlesinger Law Firm for their high quality of professionalism and persistence in pursuing my lawsuit. They always made me feel part of their family.
Dedicated to Your Case Schlesinger Law Offices, P.A. is proud to be a part of helping South Florida injury victims pursue just compensation. To date, we have won millions on behalf of our clients.
Let Us Help You
Obtain the Justice You Deserve